LB
16
9
EBAY
42
2
CCL
68
6
IBM
53
2
MKC
54
3
KR
50
5
TXN
29
4
CTSH
55
3
APA
30
5
GILD
55
5
CMCSA
49
3
WHR
61
3
CCI
30
2
VTR
44
4
BAX
38
2
FE
34
4
HCP
54
2
ETN
64
4
OMC
37
2
NKE
36
2
LB
16
9
EBAY
42
2
CCL
68
6
IBM
53
2
MKC
54
3
KR
50
5
TXN
29
4
CTSH
55
3
APA
30
5
GILD
55
5
CMCSA
49
3
WHR
61
3
CCI
30
2
VTR
44
4
BAX
38
2
FE
34
4
HCP
54
2
ETN
64
4
OMC
37
2
NKE
36
2
Financhill
Back

Xtant Medical Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
27

XTNT
Xtant Medical Holdings

Last Price:
$0.38
Seasonality Move:
20.25%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
27
Xtant Medical Holdings (XTNT) is a Sell

Is Xtant Medical Holdings a Buy, Sell or Hold?

  • The current Xtant Medical Holdings [XTNT] share price is $0.36. The Score for XTNT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • XTNT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTNT Stock Price Chart

What is Xtant Medical Holdings's stock price today?

  • The Xtant Medical Holdings share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTNT is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

XTNT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 27.25 Sell
Chaikin Money Flow: -109875 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.37 - 0.41) Sell
Bollinger Bands (100): (0.44 - 0.66) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

XTNT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.47 Sell
200-day SMA: 0.69 Sell
8-day EMA: 0.37 Sell
20-day EMA: 0.39 Sell
50-day EMA: 0.46 Sell
200-day EMA: 0.66 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

Xtant Medical Holdings Earnings Growth & XTNT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Xtant Medical Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):